Colin F. Kwok
Sutton Upon Derwent, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
MIF-CD74 signaling drives immune modulation in medulloblastoma.
Journal: Neuro-oncology
Published: June 13, 2025
MIF-CD74 signaling drives immune modulation in medulloblastoma.
Journal: Neuro-oncology
Published: June 13, 2025
Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.
Journal: The Journal of clinical investigation
Published: October 08, 2019
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma.
Journal: Oncotarget
Published: September 24, 2019
Adaptation of tape removal test for measurement of sensitivity in perineal area of rat.
Journal: Experimental neurology
Published: May 14, 2019
Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.
Journal: International journal of molecular sciences
Published: June 10, 2017
Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle.
Journal: Cell reports
Published: April 12, 2017
The Chemorepulsive Protein Semaphorin 3A and Perineuronal Net-Mediated Plasticity.
Journal: Neural plasticity
Published: September 18, 2015
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Journal: Cancer cell
Published: April 25, 2014
Last Updated: 09/26/2026